Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 9 June 2009, doi:10.1136/bmj.b2342
Cite this as: BMJ 2009;338:b2342
| The first 150 words of the full text of this article appear below. |
We were surprised that no histopathology opinion was sought in discussing the implications of histopathological examination of breast tissue excised during breast reduction surgery.1
Mammographic screening entails radiological examination of the entire breast. "Tissue screening" exclusion of malignancy would entail examining all the tissue histologically since most ductal carcinoma in situ is not visible on gross examination. However, given the available resources, it would be impractical to submit all tissue from breast reduction specimens for histological examination as this would entail many tens of tissue blocks from each case. Even if the entire specimen were submitted, only about 0.15% (a 4 µm section from each 3-4 mm tissue block) would be examined under the microscope.
The commentaries suggested that the specimen should be oriented as this "would seem to need little extra work." However, reduction specimens are often received in multiple pieces, each of which would need to be oriented.
Anthony G Douglas-Jones, consultant histopathologist1, Murali Varma, consultant histopathologist1
1 University Hospital of Wales, Heath Park, Cardiff CF14 4XN
douglas-Jones@cf.ac.uk